鍵凱科技提供高品質(zhì)8臂PEG馬來(lái)酰亞胺(三季戊四醇)產(chǎn)品，產(chǎn)品取代率≥90%。
鍵凱科技的鹽酸鹽8臂PEG馬來(lái)酰亞胺(三季戊四醇)衍生物可以交聯(lián)成可降解的PEG水凝膠。以三聚季戊四醇為核聚合而成的8ARM(TP)-PEG原料比以六聚甘油為核聚合而成的8ARM-PEG具有分散度低，分子量更精確的優(yōu)勢(shì)。PEG水凝膠在醫(yī)療設(shè)備及再生醫(yī)學(xué)中具有多種應(yīng)用，尤其適用于藥物緩釋、2D與3D細(xì)胞培養(yǎng)及傷口的密封與愈合等領(lǐng)域。
鍵凱科技提供8ARM(TP)-MAL分子量 10000Da, 20000 Da,40000 Da產(chǎn)品 1克和10克包裝。
鍵凱科技提供分裝服務(wù)，需要收取分裝費(fèi)用，如果您需要分裝為其他規(guī)格請(qǐng)與我們聯(lián)系。
鍵凱科技同時(shí)提供其他分子量的8ARM(TP)-MAL產(chǎn)品，如你需要請(qǐng)與我司sales@jenkem.com聯(lián)系。
鍵凱科技提供大批量生產(chǎn)產(chǎn)品及GMP級(jí)別產(chǎn)品，如需報(bào)價(jià)請(qǐng)與我們聯(lián)系。
References:
1. Manzoli, V., et al., Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol, American Journal of Transplantation, 2018, 18(3):590-603.
2. Dudani, J. S., et al., Sustained-Release Synthetic Biomarkers for Monitoring Thrombosis and Inflammation Using Point-of-Care Compatible Readouts. Adv. Funct. Mater., 2016.
3. Lu, H.D., et al., Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanism. Biomaterials, 2012, 33(7): p. 2145-2153.
關(guān)鍵字： 8ARM(TP)-PEG-MAL
Founded in 2001 by experts in PEG synthesis and PEGylation, JenKem Technology specializes in high-purity, low polydispersity polyethylene glycol (PEG) derivatives, PEG co-polymers, monodisperse PEGs, custom PEG derivative synthesis and PEGylation services. Specific strengths are supported by access to bulk ethylene oxide and the performance of all polymerizations and derivatizations in-house.
JenKem Technology supplies PEG derivatives worldwide, from R&D through GMP commercial quantities, for preclinical, clinical trials, and commercial products for pharma, biotech, medical devices, and dia